ps 88

ps 88 Kobe Sanders tied a season high with 27 points as Nevada claimed fifth place in the Charleston Classic with a 90-78 victory over Oklahoma State Sunday afternoon in South Carolina. Sanders helped the Wolfpack (6-1) earn a second win following one-possession games against Vanderbilt and VCU. After hitting the decisive 3-pointer with five seconds left in Friday's 64-61 win over VCU, Sanders made 7 of 10 shots, hit three 3s and sank 10 of 13 free throws Sunday. Nick Davidson added 223 points as Nevada led by as many as 19 and shot 58.9 percent. Brandon Love contributed 11 on 5-of-5 shooting as the Wolfpack scored 46 points in the paint and scored at least 85 for the fourth time this season. Marchelus Avery led the Cowboys (4-2) with 15 points and Arturo Dean added 13. Robert Jennings and Abou Ousmane added 11 apiece but leading scorer Bryce Thompson was held to seven points on 1-of-9 shooting as Oklahoma State shot 42 percent and 73.2 percent (30-of-41) at the line. After Avery's 3 forged a 12-12 tie with 13:41 remaining, Nevada gradually gained separation. The Wolfpack took a 24-15 lead on Chuck Bailey's jumper in the paint with 8:28 left but the Cowboys inched back, getting within 33-31 on a dunk by Avery with 4:11 left. Another Bailey jumper staked Nevada to a 40-33 lead by halftime. Nevada began pulling away early in the second half as it scored eight in a row for a 52-40 lead on a basket by Love with 16:44 left. A 3 by Sanders opened a 62-43 lead with 14:06 remaining before Oklahoma State charged back. After Nevada made eight straight shots, the Cowboys countered with 11 straight points and trailed 62-54 with 11:19 left on a 3-pointer by Avery. Thompson made his first basket by sinking a jumper with 10:37 left to get Oklahoma State within 64-56 left, and Keller's triple cut the margin to 70-64 nearly three minutes later. The Cowboys were within 78-72 on a basket by Avery with 3:56 remaining, but he fouled out about a minute later and the Wolfpack outscored Oklahoma State 12-6 the rest of the way as Sanders sank five free throws. --Field Level MediaPublishers testified at trial that they could not switch away from Google, even when it rolled out features they disliked. ALEXANDRIA - The US Department of Justice made its final argument on Nov 25 that Google illegally dominated online advertising technology, seeking a second antitrust win against the company. The closing arguments in Alexandria, Virginia, cap a 15-day trial held in September where prosecutors sought to show Google monopolised markets for publisher ad servers and advertiser ad networks, and tried to dominate the market for ad exchanges which sit between buyers and sellers. “Google rigged the rules of the road,” said DOJ lawyer Aaron Teitelbaum, who asked the judge to hold Google accountable for anticompetitive conduct. Google has argued prosecutors are bending US antitrust law to force it to accommodate competitors’ services, and that the case is focused on incidents from years past when Google was still building and improving its offerings. Publishers testified at trial that they could not switch away from Google, even when it rolled out features they disliked, since there was no other way to access the huge advertising demand within Google’s ad network. News Corp in 2017 estimated losing at least US$9 million (S$12.12 million) in ad revenue that year if it had switched away, one witness said. If US District Judge Leonie Brinkema finds that Google broke the law, she would consider prosecutors’ request to make Google at least sell off Google Ad Manager, a platform that includes the company’s publisher ad server and its ad exchange. Google offered to sell the ad exchange this year to end an EU antitrust investigation but European publishers rejected the proposal as insufficient, Reuters first reported in September. Analysts view the ad tech case as a smaller financial risk than the case where a judge ruled Google maintains an illegal monopoly in online search, and where prosecutors have argued the company must be forced to sell its Chrome browser. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you. Read 3 articles and stand to win rewards Spin the wheel nowA lawyer working with to select top health officials for the next Trump administration has petitioned the federal government to revoke its approval of the lifesaving polio vaccine for children ― and he could have a prominent job in a Health and Human Services Department led by Kennedy. revealed the connection in a report Friday, finding that Aaron Siri, the lawyer Kennedy has been consulting, has filed multiple legal petitions to block vaccines on behalf of the Informed Consent Action Network in recent years. That includes a for the Food and Drug Administration to withdraw its approval of a standard polio vaccine for babies and children, claiming the agency needs to do further studies to prove its safety. Polio can cause paralysis and death. Before the vaccine was approved in 1955, there were about of polio every year in the U.S. Today the disease has nearly been eradicated among Americans, though . In recent months, the deadly disease has in Gaza. On behalf of ICAN, Siri has also petitioned the FDA to suspend vaccines for hepatitis A, tetanus and diphtheria. When reached for comment, the FDA said it was “continuing to review these petitions” from Siri but that it “cannot predict when the reviews will be completed.” “Until such time, we cannot comment further,” a spokesperson for the department said. The U.S. Centers for Disease Control and Prevention declined to comment for this story. Siri could have a top job at the HHS if the Senate confirms Kennedy, a prominent vaccine skeptic, as President-elect Donald Trump’s nominee to lead the department. According to the , Kennedy has been privately expressing interest in making Siri general counsel for the department. If confirmed, Kennedy would oversee the FDA and multiple other federal public health agencies. Siri declined to comment to the Times, but a spokesperson for Kennedy said Siri has not discussed his petitions with any of the health nominees. “Mr. Kennedy has long said that he wants transparency in vaccines and to give people choice,” the spokesperson said. Trump has expressed openness toward some of Kennedy’s baseless vaccine concerns. In his Time magazine “ ” interview published Thursday, he suggested there could be merit in the unfounded claim that vaccines cause autism. “We’re going to have a big discussion,” when asked if he would sign off on Kennedy ending childhood vaccination programs. “The autism rate is at a level that nobody ever believed possible. If you look at things that are happening, there’s something causing it.” He made similar remarks during an appearance last weekend on NBC’s “ .” “I think vaccines are — certain vaccines — are incredible. But maybe some aren’t. And if they aren’t, we have to find out,” Trump said. He also described the polio vaccine as “the greatest thing,” saying: “If somebody told me to get rid of the polio vaccine, they’re going to have to work real hard to convince me.” Related...

Last month, the film adaptation of the popular Broadway musical, “ Wicked ,” released in theaters, breaking box office records. A viral post online prompts people to share photos they took while watching the movie. “Show ur ‘wicked part 1’ photos,” the post says. Although many people are aware that video recording inside the theater is illegal, others replied to the post with photos they took in their local movie theater, sparking a discussion online about whether it’s legal to take those pictures. Movie theater chain Alamo Drafthouse responded to the post calling for photos, writing “Or, don't do that.” THE QUESTION Is it illegal to take pictures of movies at the theaters? THE SOURCES United States Code 2319B Eisner Gorin LLP AMC Theaters Regal THE ANSWER Yes, it is illegal to take pictures of movies at the theaters. WHAT WE FOUND Taking photos of a movie in theaters is illegal under federal copyright laws. Movie theaters also ban the practice. United States Code 2319B states that “any person who, without the authorization of the copyright owner, knowingly uses or attempts to use an audiovisual recording device to transmit or make a copy of a motion picture or other audiovisual work protected under title 17, or any part thereof, from a performance of such work in a motion picture exhibition facility” could face up to three years in prison, fines, or both. If it's a subsequent offense, prison time can increase to up to six years. Audiovisual recording devices are defined under the law to be “a digital or analog photographic or video camera, or any other technology or device capable of enabling the recording or transmission of a copyrighted motion picture or other audiovisual work.” By that definition, cell phones or any still image camera would be included. In addition, the crime is not limited to distributing or sharing illegal work. The very act of taking the picture is in itself illegal. While the law “emerged in response to the growing threat of piracy in the digital age,” Eisner Gorin LLP says it “targets the act of recording itself, regardless of whether the recorded content is distributed or used for personal gain.” Federal law gives theater employees the authority to detain anyone suspected of violating the law. Many movie theaters have outlined in their rules that filming or taking photos during a movie is strictly prohibited. For example, Regal’s admittance policy says , “No recording devices (cameras, video recorders, sound recorders, etc.) are permitted to be used within any Regal Entertainment Group facility.” AMC Theaters has a similar policy, with its code of conduct stating , “In support of federal law, camera use is not permitted in our auditoriums” Related Articles Social media impersonation accounts are illegal in some states, if they’re intentionally deceitful No, T-Mobile is not fining customers over their text message content Are surprise restaurant fees illegal? It depends on where you are The VERIFY team works to separate fact from fiction so that you can understand what is true and false. Please consider subscribing to our daily newsletter , text alerts and our YouTube channel . You can also follow us on Snapchat , Instagram , Facebook and TikTok . Learn More » Follow Us YouTube Snapchat Instagram Facebook TikTok Want something VERIFIED? Text: 202-410-8808

OpenAI's legal battle with Elon Musk reveals internal turmoil over avoiding AI 'dictatorship'

HALIFAX — Former Halifax mayor Mike Savage has been sworn in as Nova Scotia’s 34th lieutenant-governor. Savage was installed during a ceremony today at the Nova Scotia legislature. Prime Minister Justin Trudeau announced Savage’s appointment as the King’s representative in Nova Scotia in October. He replaces Arthur J. LeBlanc who had held the position since 2017 and who carried out his last official function on Thursday, presiding over the swearing in of the provincial government’s new cabinet. Savage served 12 years as mayor of Atlantic Canada’s largest city and announced in February that he wouldn’t seek re-election. Previous to becoming mayor, Savage served for seven years as the MP for the federal riding of Dartmouth-Cole Harbour. This report by The Canadian Press was first published Dec. 13, 2024. The Canadian PressStingy Devils open home-and-home with Hurricanes

Colgate-Palmolive Co. stock underperforms Thursday when compared to competitors despite daily gainsDarius Tahir | (TNS) KFF Health News President-elect Donald Trump’s choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace — celebrity doctor Mehmet Oz — recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest. Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the health care sector, such as Amazon. Collectively, Oz’s investments total tens of millions of dollars, according to financial disclosures he filed during his failed 2022 run for a Pennsylvania U.S. Senate seat. Trump said Tuesday he would nominate Oz as administrator of the Centers for Medicare & Medicaid Services. The agency’s scope is huge: CMS oversees coverage for more than 160 million Americans, nearly half the population. Medicare alone accounts for approximately $1 trillion in annual spending, with over 67 million enrollees. UnitedHealth Group is one of the largest health care companies in the nation and arguably the most important business partner of CMS, through which it is the leading provider of commercial health plans available to Medicare beneficiaries. UnitedHealth also offers managed-care plans under Medicaid, the joint state-federal program for low-income people, and sells plans on government-run marketplaces set up via the Affordable Care Act. Oz also had smaller stakes in CVS Health, which now includes the insurer Aetna, and in the insurer Cigna. It’s not clear if Oz, a heart surgeon by training, still holds investments in health care companies, or if he would divest his shares or otherwise seek to mitigate conflicts of interest should he be confirmed by the Senate. Reached by phone on Wednesday, he said he was in a Zoom meeting and declined to comment. An assistant did not reply to an email message with detailed questions. “It’s obvious that over the years he’s cultivated an interest in the pharmaceutical industry and the insurance industry,” said Peter Lurie, president of the Center for Science in the Public Interest, a watchdog group. “That raises a question of whether he can be trusted to act on behalf of the American people.” (The publisher of KFF Health News, David Rousseau, is on the CSPI board .) Oz used his TikTok page on multiple occasions in November to praise Trump and Robert F. Kennedy Jr., including their efforts to take on the “illness-industrial complex,” and he slammed “so-called experts like the big medical societies” for dishing out what he called bad nutritional advice. Oz’s positions on health policy have been chameleonic; in 2010, he cut an ad urging Californians to sign up for insurance under President Barack Obama’s Affordable Care Act, telling viewers they had a “historic opportunity.” Oz’s 2022 financial disclosures show that the television star invested a substantial part of his wealth in health care and food firms. Were he confirmed to run CMS, his job would involve interacting with giants of the industry that have contributed to his wealth. Given the breadth of his investments, it would be difficult for Oz to recuse himself from matters affecting his assets, if he still holds them. “He could spend his time in a rocking chair” if that happened, Lurie said. In the past, nominees for government positions with similar potential conflicts of interest have chosen to sell the assets or otherwise divest themselves. For instance, Treasury Secretary Janet Yellen and Attorney General Merrick Garland agreed to divest their holdings in relevant, publicly traded companies when they joined the Biden administration. Trump, however, declined in his first term to relinquish control of his own companies and other assets while in office, and he isn’t expected to do so in his second term. He has not publicly indicated concern about his subordinates’ financial holdings. CMS’ main job is to administer Medicare. About half of new enrollees now choose Medicare Advantage, in which commercial insurers provide their health coverage, instead of the traditional, government-run program, according to an analysis from KFF, a health information nonprofit that includes KFF Health News. Proponents of Medicare Advantage say the private plans offer more compelling services than the government and better manage the costs of care. Critics note that Medicare Advantage plans have a long history of costing taxpayers more than the traditional program. UnitedHealth, CVS, and Cigna are all substantial players in the Medicare Advantage market. It’s not always a good relationship with the government. The Department of Justice filed a 2017 complaint against UnitedHealth alleging the company used false information to inflate charges to the government. The case is ongoing. Oz is an enthusiastic proponent of Medicare Advantage. In 2020, he proposed offering Medicare Advantage to all; during his Senate run, he offered a more general pledge to expand those plans. After Trump announced Oz’s nomination for CMS, Jeffrey Singer, a senior fellow at the libertarian-leaning Cato Institute, said he was “uncertain about Dr. Oz’s familiarity with health care financing and economics.” Singer said Oz’s Medicare Advantage proposal could require large new taxes — perhaps a 20% payroll tax — to implement. Oz has gotten a mixed reception from elsewhere in Washington. Pennsylvania Sen. John Fetterman, the Democrat who defeated Oz in 2022, signaled he’d potentially support his appointment to CMS. “If Dr. Oz is about protecting and preserving Medicare and Medicaid, I’m voting for the dude,” he said on the social platform X. Oz’s investments in companies doing business with the federal government don’t end with big insurers. He and his family also hold hospital stocks, according to his 2022 disclosure, as well as a stake in Amazon worth as much as nearly $2.4 million. (Candidates for federal office are required to disclose a broad range of values for their holdings, not a specific figure.) Amazon operates an internet pharmacy, and the company announced in June that its subscription service is available to Medicare enrollees. It also owns a primary care service , One Medical, that accepts Medicare and “select” Medicare Advantage plans. Oz was also directly invested in several large pharmaceutical companies and, through investments in venture capital funds, indirectly invested in other biotech and vaccine firms. Big Pharma has been a frequent target of criticism and sometimes conspiracy theories from Trump and his allies. Kennedy, whom Trump has said he’ll nominate to be Health and Human Services secretary, is a longtime anti-vaccine activist. During the Biden administration, Congress gave Medicare authority to negotiate with drug companies over their prices. CMS initially selected 10 drugs. Those drugs collectively accounted for $50.5 billion in spending between June 1, 2022, and May 31, 2023, under Medicare’s Part D prescription drug benefit. At least four of those 10 medications are manufactured by companies in which Oz held stock, worth as much as about $50,000. Related Articles National Politics | After Trump’s Project 2025 denials, he is tapping its authors and influencers for key roles National Politics | Republicans push back against Democrats’ claims that Trump intelligence pick Gabbard is compromised National Politics | Trump 2.0 has a Cabinet and executive branch of different ideas and eclectic personalities National Politics | California raw milk recalled after positive test for bird flu virus National Politics | Senators took down one Trump Cabinet pick. But the fight over their authority is just beginning Oz may gain or lose financially from other Trump administration proposals. For example, as of 2022, Oz held investments worth as much as $6 million in fertility treatment providers. To counter fears that politicians who oppose abortion would ban in vitro fertilization, Trump floated during his campaign making in vitro fertilization treatment free. It’s unclear whether the government would pay for the services. In his TikTok videos from earlier in November, Oz echoed attacks on the food industry by Kennedy and other figures in his “Make America Healthy Again” movement. They blame processed foods and underregulation of the industry for the poor health of many Americans, concerns shared by many Democrats and more mainstream experts. But in 2022, Oz owned stakes worth as much as $80,000 in Domino’s Pizza, Pepsi, and US Foods, as well as more substantial investments in other parts of the food chain, including cattle; Oz reported investments worth as much as $5.5 million in a farm and livestock, as well as a stake in a dairy-free milk startup. He was also indirectly invested in the restaurant chain Epic Burger. One of his largest investments was in the Pennsylvania-based convenience store chain Wawa, which sells fast food and all manner of ultra-processed snacks. Oz and his wife reported a stake in the company, beloved by many Pennsylvanians, worth as much as $30 million. ©2024 KFF Health News. Distributed by Tribune Content Agency, LLC.

Rethinking screen time: A better understanding of what people do on their devices is key to digital well-beingIn the HBO documentary “Surveilled,” Pulitzer Prize-winning journalist Ronan Farrow travels across the globe to investigate and expose the dark underbelly of the multi-billion-dollar advanced spyware industry. The film reveals that repressive regimes aren’t alone in using spyware to hack into citizens’ cell phones and computers clandestinely; democratic governments are also guilty of spying on unknowing individuals. “In recent years, we have seen a succession of Western democracies, where people really thought, “It can’t happen here” have these scandals where the use of commercial spyware technology spirals out of control despite constitutions in place that should prevent it,” says Farrow, whose most recent article for the New Yorker details how the Trump administration could expand the use of commercial spyware in the U.S. The article examines the Department of Homeland Security’s recently signed two-million-dollar contract with the Israeli spyware company Paragon. “A number of experts told me that the Department of Homeland Security acquiring this technology doesn’t necessarily mean, even if it’s intended for ICE (Immigration and Customs Enforcement), that it will only be used by ICE for immigration purposes,” says Farrow. “Not that we should lack concern about ICE marrying up Donald Trump ‘s promise of mass deportation with advanced spyware technology. But a lot of the privacy law experts that I spoke with told me that we should all really be concerned even if you don’t think of yourself as being in a vulnerable category. Even if you are not a politician, an activist, or a journalist, you are still looking at a situation where you might not know that you are being targeted until after the fact, and that’s another reason why it was important to me in this documentary, to tell the stories of innocent bystanders who are apolitical, who get caught up in these dragnets.” Farrow began reporting on the spyware industry after he was the target of cyber surveillance during his investigation into Harvey Weinstein that would help launch the 2017 #MeToo movement. “I came to (this subject) quite naturally in the course of being surveilled in various ways myself while reporting on tricky stories that pissed people off,” says Farrow. “It was personally frightening and devastating. It’s not just information gathering; there is a dimension of intimidation to it and, maybe even more consequentially, it shrinks the space for us to do our work as journalists.” Directed by Matthew O’Neill and Perri Peltz, “Surveilled” takes viewers inside the secretive industry while also illuminating how the digital spy business is reshaping contemporary concepts of privacy and power. The docu, which made its world debut at DOC NYC this month, examines ethical dilemmas that citizens and governments must now navigate in the brave new world of cyberespionage. Variety spoke to Farrow about Trump, the future of the #MeToo movement, and how to fend off being hacked. Farrow: I try to stay away from speculation other than talking about the capacities we have right now, the promises being made, and how those could collide in scary ways. We don’t know what will happen, but I do know that an array of serious privacy law experts are in a state of high alarm now looking at the fact that Donald Trump is making this promise of mass deportation. Also, the threats he is making to subject political enemies to tribunals and the idea he has conveyed that journalists who protect sources should go to jail have put privacy law experts in a high state of alarm (because) those promises become a lot scarier when married up with this kind of (spy) technology that his administration will have at its fingertips. It’s a huge concern. If we want freedom of expression and freedom of information, then we need to have privacy rights and devices that can’t be so easily compromised. We need to have checks and balances on these (spy) tools, and one of the big casualties when those checks and balances go away and when these devices are just a public space, and there is no room for private conversations, is journalism. I don’t want to see a reality in which the Trump administration makes good on what he’s saying about imprisoning people in our profession who protect their sources. Unfortunately, that reality becomes a lot more likely to transpire if this tech is used in an unfettered way. Write to your representatives and call them to say that you want accountability on this issue. While there are few complete defenses against advanced hacking technology, a daily reboot of your phone is something multiple tech experts have advised in the course of my reporting. I can’t give a satisfying answer to the question because the important part of my relationship with that reporting is that I really was just acting not as an activist but as an investigative reporter. The separate issue that you raised about Trump’s appointments, I think, is just linked to this wider pattern that we are seeing with those appointments, which has been described by very credible journalists in recent days as a trolling operation. Having people who have disregarded and flouted the very thing that the agency they are going to be running is designed to protect that’s happening over and over again. So, while it has a dimension of perhaps nose-thumbing at standards of consent and accountability around sexual violence, it is really just part and parcel with a moment in which this administration is coming in with a lot of evidence of a lot of different types of disregard for the rule of law. “Surveilled” is currently streaming on Max.

Target Has the Coolest Black Friday Toy Deal for Gamers